We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+10.97%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.8B
AUM Growth
+$11.7B
(+70,685%)
Cap. Flow
+$973M
Cap. Flow
% of AUM
8.28%
Top 10 Holdings %
Top 10 Hldgs %
24.41%
Holding
296
New
40
Increased
100
Reduced
97
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$166M |
| 2 |
Amgen
AMGN
|
+$123M |
| 3 |
Autodesk
ADSK
|
+$114M |
| 4 |
UnitedHealth
UNH
|
+$103M |
| 5 |
Merck
MRK
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$78.6M |
| 2 |
Advanced Micro Devices
AMD
|
+$74.2M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$65.6M |
| 4 |
Union Pacific
UNP
|
+$36.4M |
| 5 |
Illumina
ILMN
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.57% |
| 2 | Financials | 22.21% |
| 3 | Healthcare | 21.91% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRNB
226
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.92M | 0.02% |
+100,000
| New | +$2.82M |
|
|
NVRO
227
DELISTED
NEVRO CORP.
NVRO
| $2.85M | 0.02% |
50,000
+10,000
| +25% | +$625K |
|
228
KVH Industries
KVHI
$171M
| $2.8M | 0.02% |
213,997
+28,600
| +15% | +$360K |
|
|
OBSV
229
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $2.71M | 0.02% |
+150,000
| New | +$2.2M |
|
230
Analog Devices
ADI
$172B
| $2.56M | 0.02% |
27,688
| – | – |
|
|
MIXT
231
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $2.51M | 0.02% |
173,954
-98,068
| -36% | -$1.62M |
|
232
HDFC Bank
HDB
$122B
| $2.48M | 0.02% |
105,420
+2,488
| +2% | +$63.4K |
|
233
Replimune Group
REPL
$426M
| $2.42M | 0.02% |
+150,000
| New | +$2.63M |
|
|
VIVE
234
DELISTED
VIVEVE MED INC
VIVE
| $2.41M | 0.02% |
898
-302
| -25% | -$856K |
|
235
Protolabs
PRLB
$1.7B
| $2.35M | 0.02% |
14,561
-58,525
| -80% | -$8.28M |
|
|
TWTR
236
DELISTED
Twitter, Inc.
TWTR
| $2.33M | 0.02% |
82,000
-6,553
| -7% | -$232K |
|
237
CALL
Apple
AAPL
$5T
| $2.26M | 0.02% |
29,200
| – | – |
|
238
iRhythm Holdings
IRTC
$3.97B
| $2.08M | 0.02% |
22,000
-240,011
| -92% | -$20.9M |
|
239
ProQR Therapeutics
PRQR
$243M
| $1.94M | 0.02% |
+100,000
| New | +$1.06M |
|
|
DESP
240
DELISTED
Despegar.com
DESP
| $1.91M | 0.02% |
113,097
| – | – |
|
241
Tesla
TSLA
$1.19T
| $1.71M | 0.01% |
96,975
-162,555
| -63% | -$3.39M |
|
|
AUTL
242
Autolus Therapeutics
AUTL
$378M
| $1.53M | 0.01% |
50,000
| – | – |
|
|
VRNA
243
DELISTED
Verona Pharma
VRNA
| $1.25M | 0.01% |
100,000
| – | – |
|
|
IMMP
244
Immutep
IMMP
$56.1M
| $909K | 0.01% |
+245,698
| New | +$675K |
|
245
Esquire Financial Holdings
ESQ
$1.12B
| $903K | 0.01% |
36,180
-2,130
| -6% | -$54.4K |
|
|
JOBS
246
DELISTED
51job Inc
JOBS
| $844K | 0.01% |
+10,953
| New | +$875K |
|
247
Summit Therapeutics
SMMT
$9.84B
| $777K | 0.01% |
350,000
| – | – |
|
248
Goldman Sachs
GS
$291B
| $771K | 0.01% |
3,439
-718
| -17% | -$167K |
|
|
VNET
249
VNET Group
VNET
$1.79B
| $695K | 0.01% |
68,785
+45,256
| +192% | +$442K |
|
|
FENG
250
Phoenix New Media
FENG
$17.5M
| $592K | 0.01% |
+23,380
| New | +$618K |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q3 2018 Portfolio in Review
As of Q3 2018, Polar Capital held 296 positions worth $11.8B, up 70,685% from $16.6M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Polar Capital deployed $973M of net new capital in Q3 2018, opening 40 new positions and adding to 100 existing holdings. Its largest new stake was Johnson & Johnson: 1,250,000 shares worth $173M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $78.6M trimmed.
- Polar Capital's largest Q3 2018 buy was Johnson & Johnson: 1,250,000 shares worth $173M.
- Polar Capital added most to UnitedHealth in Q3 2018, an estimated $103M increase.
- Polar Capital's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $78.6M.
- Polar Capital fully exited Amdocs in Q3 2018, selling an estimated $46.6K.
- Polar Capital's ten largest holdings make up 24% of its $11.8B portfolio in Q3 2018.
- Polar Capital opened 40 new positions and closed 30 in Q3 2018.
- Polar Capital's portfolio value rose 70,685% quarter-over-quarter to $11.8B.
Based on Polar Capital's 13F filing for Q3 2018, filed 14 Nov 2018.